Skip to main content
Premium Trial:

Request an Annual Quote

Rosetta Genomics' H1 2011 Revenues Fall 39 Percent

NEW YORK (GenomeWeb News) – Rosetta Genomics' first-half 2011 revenues fell 39 percent year over year, the Israeli microRNA-based molecular diagnostics company reported after the close of the market on Friday.

In a document filed with the US Securities and Exchange Commission, it said that revenues for the first six months of the year came in at $59,000, down from $97,000 a year ago.

Its net loss for the period was cut by 41 percent to $4.5 million, or $.62 per share, from $7.6 million, or $1.88 per share, a year ago, however.

The firm's R&D spending for the six months slid 36 percent to $2.3 million from $3.6 million a year ago, while SG&A costs dropped 23 percent to $3.3 million from $4.3 million.

It ended the half-year with $3.1 million in cash and cash equivalents.

The company has struggled with its finances and in July carried out a one-for-four reverse stock split in order to continue listing on Nasdaq, which had threatened to delist it for failing to satisfy a requirement calling for a minimum $1 per share price.

In its SEC filing, Rosetta said that it is "addressing its liquidity issues by implementing initiatives … [that] include a potential equity financing and costs reduction."

The Scan

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.

Algorithm Teases Out Genetic Ancestry in Individuals at Biobank Scale

Researchers develop an algorithm known as Rye to tease apart ancestry fractions in admixed individuals at a biobank-scale, applying it to 488,221 UK Biobank participants in Nucleic Acids Research.

Multi-Ancestry Analysis Highlights Comparable Common Variants at Complex Trait-Linked Loci

Researchers in Nature Genetics examine common variants implicated in more than three dozen conditions, estimating genetic effect similarities across ancestry tracts in admixed individuals.

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.